[PHAT] YoY Annual Result on 31-Dec-2023 [#FY]

Stock
[PHAT] Phathom Pharmaceuticals, Inc.
Announcement Date
14-Jun-2024
Financial Year
2023
Quarter
31-Dec-2023 [#FY]
Profit Trend
YoY- 9.60%
Quarter Report
PHAT's Result
PHAT's Financial Summary
View:
Show?
Annual Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
Revenue 682 0 0 0 0 0 -
PBT -201,592 -197,723 -143,883 -129,068 -255,131 -1,288 174.58%
Tax 0 25,283 4,211 4,250 -45,387 13 -
NP -201,592 -223,006 -148,094 -133,318 -209,744 -1,288 174.58%
Tax Rate - - - - - - -
Total Cost 202,274 223,006 148,094 133,318 209,744 1,288 174.76%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
NP Margin -29,558.94 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
EPS -3.93 -5.70 -4.00 -4.01 -8.48 -0.15 92.09%
EPS Diluted -3.93 -5.70 -4.00 -4.01 -8.48 -0.15 92.09%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.